NB Therapeutics nitricbio.com


Public lists: Pharma Startups (4732)

NB Therapeutics, formerly Theranox, is a biopharmaceutical and medical device company focused on developing and commercializing pharmacologic therapies to address opportunities in the dermatology and podiatry markets with unmet needs. NB Therapeutics has two technology platforms: iontophoresis and nitric oxide gas. Through these two technology platforms, NB Therapeutics seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company has advanced compoun...Show all

NB Therapeutics, formerly Theranox, is a biopharmaceutical and medical device company focused on developing and commercializing pharmacologic therapies to address opportunities in the dermatology and podiatry markets with unmet needs. NB Therapeutics...Show all

Company (Alive / Active)

Phone: 215-788-6200

Fax:

2 Canals End Road
Bristol, 19007
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NB Therapeutics $11.5M Jan 20, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NB Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors

CVRx

Minneapolis, Minnesota, United States
Alive / ActiveCVRx is a privately held company founded in 2001 and headquartered in Minneapolis, Minnesota. The company has developed the second-generation BAROSTIM NEO, a minimally-invasive implantable system and the only device CE Marked for the separate indications of heart failure and resistant hypertension. BAROSTIM NEO is commercially available in over 20 countries and under clinical evaluation for the treatment of heart failure and hypertension in the United States. The company's BAROSTIM NEO LEGACY ho...Show allLogin to see details

Spiration

Redmond, Washington, United States
AcquiredSpiration was founded to develop treatments for chronic obstructive pulmonary disease.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Media compliation system Jun 20, 2013 Application